Vaccine

SEP 27, 2026 · JOURNAL ARTICLE

Cationic surfactant-dependent enhancement of antigen-specific cellular immunity by a biodegradable nanoparticle vaccine

Vaccine

Infectious diseases remain a leading cause of morbidity and mortality worldwide and while antimicrobials play a crucial role in controlling infections, the rise of antimicrobial re

JUL 20, 2026 · JOURNAL ARTICLE

ChAdOx1 nCoV-19 coronavirus vaccine: Long-term safety and immunological responses

Vaccine

Prospective follow-up of pre-licensure trial participants with 4470 enrollees and 86% completion rate found no emergent safety signals over 11.77 months median follow-up, supporting the established safety profile of ChAdOx1 nCoV-19 vaccine.